The new complex establishes the Connaught campus as the "North American Center of Excellence" in analytical and bioprocessing research and development for Sanofi Pasteur
and solidifies the Toronto site as a national strategic asset for the research, development and manufacturing of vaccines.
worked for a time on diseases of silkworms and succeeded in developing a method for isolating of healthy silkworm eggs, a feat that again proved immensely valuable to industry.
FLEXNEWS reported in July that LG Household was reviewing potential acquisition opportunities to help secure long-term growth and identified Pasteur
Milk as a possible opportunity.
Clinicians will receive instructions from Sanofi Pasteur
regarding how to return unused vaccine from these lots, the statement said.
remains in continuous communication with these health authorities to help develop a tailored response to local public health needs," he stated.
The results of these joint research projects could be utilized by the Merieux Alliance companies and would enhance the Institut Pasteur
's patent portfolio, contributing to the valorization of its research efforts.
The Royal Society of London in 1856 awarded Mr Pasteur
the Rumford Medal for his researches relative to the polarization of light and decorated with the Legion d' Honneur in 1853, he was promoted to be an officer of the Order in 1863, and commander in 1868.
Each year, sanofi pasteur
provides vaccine to hospitals and other health- care facilities; private office-based providers; retail pharmacies; community immunization providers; and to the military, veterans and children through providers' private and public vaccination programs.
, the vaccines business of the sanofi-aventis Group, today said it has generated the first clinical trial lot of a new generation of H7N1 pandemic vaccine.
Mother and son cling to hope that the famous Doctor Pasteur
can do something to help.
Canada-based Aventis Pasteur
gets a 24-month exclusive option under the terms of the agreement to evaluate Provalis's protein-based antigen vaccine candidates.
said this involved 6,700 doses in the UK, but stressed there was little risk to any patients who had received the vaccine, which had passed both factory and independent tests.